NM_000844.4:c.520-133A>C
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_000844.4(GRM7):c.520-133A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.265 in 683,554 control chromosomes in the GnomAD database, including 25,612 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.24   (  4901   hom.,  cov: 32) 
 Exomes 𝑓:  0.27   (  20711   hom.  ) 
Consequence
 GRM7
NM_000844.4 intron
NM_000844.4 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  -1.44  
Publications
10 publications found 
Genes affected
 GRM7  (HGNC:4599):  (glutamate metabotropic receptor 7) L-glutamate is the major excitatory neurotransmitter in the central nervous system, and it activates both ionotropic and metabotropic glutamate receptors. Glutamatergic neurotransmission is involved in most aspects of normal brain function and can be perturbed in many neuropathologic conditions. The metabotropic glutamate receptors are a family of G protein-coupled receptors that have been divided into three groups on the basis of sequence homology, putative signal transduction mechanisms, and pharmacologic properties. Group I includes GRM1 and GRM5, and these receptors have been shown to activate phospholipase C. Group II includes GRM2 and GRM3, while Group III includes GRM4, GRM6, GRM7 and GRM8. Group II and III receptors are linked to the inhibition of the cyclic AMP cascade but differ in their agonist selectivities. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2009] 
GRM7 Gene-Disease associations (from GenCC):
- neurodevelopmental disorder with seizures, hypotonia, and brain imaging abnormalitiesInheritance: AR Classification: STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92). 
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.296  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.242  AC: 36794AN: 152022Hom.:  4905  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
36794
AN: 
152022
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD4 exome  AF:  0.272  AC: 144515AN: 531414Hom.:  20711   AF XY:  0.272  AC XY: 76381AN XY: 281264 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
144515
AN: 
531414
Hom.: 
 AF XY: 
AC XY: 
76381
AN XY: 
281264
show subpopulations 
African (AFR) 
 AF: 
AC: 
2329
AN: 
14790
American (AMR) 
 AF: 
AC: 
4181
AN: 
28442
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
4782
AN: 
15690
East Asian (EAS) 
 AF: 
AC: 
4917
AN: 
33060
South Asian (SAS) 
 AF: 
AC: 
12262
AN: 
53944
European-Finnish (FIN) 
 AF: 
AC: 
12191
AN: 
39048
Middle Eastern (MID) 
 AF: 
AC: 
545
AN: 
2148
European-Non Finnish (NFE) 
 AF: 
AC: 
95505
AN: 
315342
Other (OTH) 
 AF: 
AC: 
7803
AN: 
28950
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.505 
Heterozygous variant carriers
 0 
 5365 
 10730 
 16096 
 21461 
 26826 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 754 
 1508 
 2262 
 3016 
 3770 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome   AF:  0.242  AC: 36797AN: 152140Hom.:  4901  Cov.: 32 AF XY:  0.241  AC XY: 17917AN XY: 74338 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
36797
AN: 
152140
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
17917
AN XY: 
74338
show subpopulations 
African (AFR) 
 AF: 
AC: 
6356
AN: 
41532
American (AMR) 
 AF: 
AC: 
2726
AN: 
15284
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
1051
AN: 
3468
East Asian (EAS) 
 AF: 
AC: 
919
AN: 
5166
South Asian (SAS) 
 AF: 
AC: 
1109
AN: 
4824
European-Finnish (FIN) 
 AF: 
AC: 
3405
AN: 
10584
Middle Eastern (MID) 
 AF: 
AC: 
68
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
20356
AN: 
67962
Other (OTH) 
 AF: 
AC: 
492
AN: 
2114
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.502 
Heterozygous variant carriers
 0 
 1434 
 2868 
 4302 
 5736 
 7170 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 390 
 780 
 1170 
 1560 
 1950 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
796
AN: 
3478
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.